Sildenafil and Big Pharma: A Volatile Bet?

The story of Sildenafil presents a challenging picture for investors. While the initial introduction generated significant gains, the expiration of its patent opened the door to off-brand competitors, dramatically reducing revenue. This creates a specific challenge for firms depending on comparable blockbuster medications, suggesting that a careles

read more

Viagra, Vegas, and Vipers: A copyright Scam?

The copyright market is known for its wild swings. This week, the newest craze seems to be a meme coin dubbed "Viagra, Vegas, and Vipers." This asset has exploded in value, fueled by rumors about its potential to revolutionize the finance industry. Some investors are optimistic, while others are cautious that this is just another pump-and-dump. {

read more